Martin Lagging
Sahlgrenska University Hospital · 193 works · 6,865 citations · h-index 38
Top works
- Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection
- Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype
- A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
- Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
- Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients
- Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein
- Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial
- Interferon (IFN)–γ–Inducible Protein–10: Association with Histological Results, Viral Kinetics, and Outcome during Treatment with Pegylated IFN‐α2a and Ribavirin for Chronic Hepatitis C Virus Infection
- IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection
- International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C
- Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection
- Functional Role of Hepatitis C Virus Chimeric Glycoproteins in the Infectivity of Pseudotyped Virus
- Randomized comparison of 12 or 24 weeks of peginterferon α-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection
- Immune responses to plasmid DNA encoding the hepatitis C virus core protein
- Progression of fibrosis in untreated patients with hepatitis C virus infection
- Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers
- Systemic and Intrahepatic Interferon-Gamma-Inducible Protein 10 Kda Predicts the First-Phase Decline in Hepatitis C Virus Rna and Overall Viral Response to Therapy in Chronic Hepatitis C
- Response Prediction in Chronic Hepatitis C by Assessment of IP-10 and IL28B-Related Single Nucleotide Polymorphisms
- Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C†
- Surveillance of wastewater revealed peaks of SARS-CoV-2 preceding those of hospitalized patients with COVID-19